- ►diabetesjournals.org EA Doyle, MSN APRN, SA Weinzimer, AT … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—While there was no significant change in the glargine group (HbA 1c
8.2% at baseline vs. 8.1% at 16 weeks), youth randomized to CSII had a sharp
reduction in HbA 1c levels, from 8.1 to 7.2% after 16 weeks of therapy (P < ... Cited by 170 - Related articles - BL Direct - All 9 versions
- ►input.me.uk [PDF] N Weintrob, H Benzaquen, A Galatzer, S … - Pediatrics, 2003 - Am Acad Pediatrics Results. The changes in HbA 1c and fructoseamine values were similar in the 2
arms over time. At the end of the study, mean HbA 1c level measured 8.05 ±
0.78%. There were no differences between the treatment modes in frequency ... Cited by 135 - Related articles - BL Direct - All 7 versions
DM Wilson, BA Buckingham, EL Kunselman, … - Diabetes Care, 2005 - care.diabetesjournals.org.p.angrylapdog.com RESULTS—The 19 subjects' ages ranged from 1.7 to 6.1 (mean 3.6) years,
duration of diabetes ranged from 0.6 to 2.6 (mean 1.4) years, and baseline HbA
1c ranged from 6.7 to 9.6% (mean 7.9%). Seven subjects were male. Nine ... Cited by 108 - Related articles - All 7 versions
LA DiMeglio, TM Pottorff, SR Boyd, L France, … - The Journal of pediatrics, 2004 - Elsevier Thirty-seven patients completed 6 months of therapy. There was a significant
decrease in HbA1c during the study period for both groups (from 8.9% ± 0.6% to
8.6% ± 0.6% at 3- and 6-month visits). At 3 months, children using pumps ... Cited by 97 - Related articles - All 13 versions
- ►angrylapdog.com LA Fox, LM Buckloh, SD Smith, T Wysocki, N … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Eleven subjects from each group completed the trial (age 46.3 ± 3.2
months [means ± SE]). At baseline, there were no differences between groups in
HbA 1c , MBG, age, sex, diabetes duration, or parental QOL. Mean HbA 1c , ... Cited by 71 - Related articles - All 9 versions
SA Weinzimer, JAH Ahern, EA Doyle, MR … - Pediatrics, 2004 - Am Acad Pediatrics Objective. Use of continuous subcutaneous insulin infusion (CSII) has increased
dramatically in recent years, and pump therapy has been shown to be a safe and
effective alternative to multiple daily injections in adults and older ... Cited by 95 - Related articles - BL Direct - All 5 versions
JAH Ahern, EA Boland, R Doane, JJ Ahern, P … - Pediatric Diabetes, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 127 - Related articles - BL Direct - All 3 versions
SM Willi, J Planton, L Egede, S Schwarz - The Journal of pediatrics, 2003 - Elsevier Before pump initiation, HbA 1C was relatively stable, but it fell to 7.7±0.2%
(P<.001) within 3 months of CSII and remained decreased (7.9±0.1%) at 12 months
(P<.01). In contrast, weight standard deviation score increased before CSII ... Cited by 77 - Related articles - All 5 versions
- ►diabetesjournals.org LP Plotnick, LM Clark, FL Brancati, T Erlinger - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—There was a small but significant decrease in HbA 1c at 3–6 months
after pump start (7.7 vs. 7.5%; P = 0.03). HbA 1c levels then gradually
increased and remained elevated after 1 year of follow-up; however, this ... Cited by 146 - Related articles - BL Direct - All 10 versions
